Xiao-Feng Zhou, Ph.D. - Publications

2001 The University of Toledo 
Molecular Biology, Pharmacology

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Zhu R, Zhang CG, Liu Y, Yuan ZQ, Chen WL, Yang SD, Li JZ, Zhu WJ, Zhou XF, You BG, Zhang XN. CD147 monoclonal antibody mediated by chitosan nanoparticles loaded with α-hederin enhances antineoplastic activity and cellular uptake in liver cancer cells. Scientific Reports. 5: 17904. PMID 26639052 DOI: 10.1038/srep17904  0.8
2006 Omwancha J, Zhou XF, Chen SY, Baslan T, Fisher CJ, Zheng Z, Cai C, Shemshedini L. Makorin RING finger protein 1 (MKRN1) has negative and positive effects on RNA polymerase II-dependent transcription. Endocrine. 29: 363-73. PMID 16785614 DOI: 10.1385/ENDO:29:2:363  0.8
2004 Allen BP, Gilbert RJ, Zhou X. A new platform for electrochemical analysis of a microtiter plate Proceedings of Spie - the International Society For Optical Engineering. 5591: 1-10. DOI: 10.1117/12.577825  0.8
2001 Shenk JL, Fisher CJ, Chen SY, Zhou XF, Tillman K, Shemshedini L. p53 represses androgen-induced transactivation of prostate-specific antigen by disrupting hAR amino- to carboxyl-terminal interaction. The Journal of Biological Chemistry. 276: 38472-9. PMID 11504717 DOI: 10.1074/jbc.M103652200  0.8
2000 Bubulya A, Zhou XF, Shen XQ, Fisher CJ, Shemshedini L. c-Jun targets amino terminus of androgen receptor in regulating androgen-responsive transcription. Endocrine. 13: 55-62. PMID 11051047 DOI: 10.1385/ENDO:13:1:55  0.8
1999 Shen XQ, Bubulya A, Zhou XF, Khazak V, Golemis EA, Shemshedini L. Ligand-free RAR can interact with the RNA polymerase II subunit hsRPB7 and repress transcription. Endocrine. 10: 281-9. PMID 10484292 DOI: 10.1007/BF02738627  0.8
1999 Zhou XF, Shen XQ, Shemshedini L. Ligand-activated retinoic acid receptor inhibits AP-1 transactivation by disrupting c-Jun/c-Fos dimerization. Molecular Endocrinology (Baltimore, Md.). 13: 276-85. PMID 9973257 DOI: 10.1210/mend.13.2.0237  0.8
1998 Wise SC, Burmeister LA, Zhou XF, Bubulya A, Oberfield JL, Birrer MJ, Shemshedini L. Identification of domains of c-Jun mediating androgen receptor transactivation. Oncogene. 16: 2001-9. PMID 9591784 DOI: 10.1038/sj.onc.1201697  0.8
1994 Markx GH, Huang Y, Zhou XF, Pethig R. Dielectrophoretic characterization and separation of micro-organisms Microbiology. 140: 585-591.  0.8
Show low-probability matches.